Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier.

Drug efflux transporters can influence the absorption, tissue distribution and elimination of many therapeutic agents. Modulation of drug efflux transporter activity is being explored as a means for improving the pharmacokinetic and pharmacodynamic properties of various drugs. In this regard, several polymer formulations have been shown to inhibit drug efflux transporters such as P-glycoprotein (P-gp). The current review will focus on Pluronic block copolymers in particular, the mechanisms involved in the effects of Pluronic on drug efflux transporters, and the optimal polymer compositions required for inhibition of drug efflux transporters. Special emphasis will be placed on the potential applications of Pluronic in enhancing the blood-brain barrier (BBB) penetration of drugs.

[1]  J. Blonder,et al.  Dose-dependent hyperlipidemia in rabbits following administration of poloxamer 407 gel. , 1999, Life sciences.

[2]  Y. Assaraf,et al.  Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells. , 1999, European journal of biochemistry.

[3]  M. Malmsten.  Block copolymers in pharmaceutics , 2000 .

[4]  A. Kabanov,et al.  Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. , 1996, Bioconjugate chemistry.

[5]  Alexander V. Kabanov,et al.  Micelle formation and solubilization of fluorescent probes in poly(oxyethylene-b-oxypropylene-b-oxyethylene) solutions , 1995 .

[6]  Alexander V. Kabanov,et al.  Effects of Pluronic P85 Unimers and Micelles on Drug Permeability in Polarized BBMEC and Caco-2 Cells , 1998, Pharmaceutical Research.

[7]  R. Borchardt,et al.  Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells. , 1997, Journal of pharmaceutical sciences.

[8]  Alexander V Kabanov,et al.  Pluronic block copolymers for overcoming drug resistance in cancer. , 2002, Advanced drug delivery reviews.

[9]  R. Edlich,et al.  Pharmacokinetics of a new skin wound cleanser. , 1976, American journal of surgery.

[10]  I. R. Schmolka.  Physical Basis for Poloxamer Interactions , 1994, Annals of the New York Academy of Sciences.

[11]  R. Hunter,et al.  The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance. , 1981, Journal of immunology.

[12]  Alexander V. Kabanov,et al.  A new class of drug carriers: micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain☆ , 1992 .

[13]  A. Kabanov,et al.  Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. , 2001, The Journal of pharmacology and experimental therapeutics.

[14]  R. Hunter,et al.  The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers. , 1984, Journal of immunology.

[15]  I. R. Schmolka.  A review of block polymer surfactants , 1977 .

[16]  Alexander V. Kabanov,et al.  Effects of Pluronic Block Copolymers on Drug Absorption in Caco-2 Cell Monolayers , 1998, Pharmaceutical Research.

[17]  R. Hunter,et al.  Effect of adjuvant formulations on the selection of B-cell epitopes expressed by a malaria peptide vaccine. , 1992, Vaccine.

[18]  A. Kabanov,et al.  Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion , 2001, British Journal of Cancer.

[19]  Donald W. Miller,et al.  Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. , 2001, The Journal of pharmacology and experimental therapeutics.

[20]  C. Jagannath,et al.  Use of nonionic block copolymers in vaccines and therapeutics. , 1998, Critical reviews in therapeutic drug carrier systems.

[21]  R. Edlich,et al.  Pluronic F-68: a promising new skin wound cleanser. , 1980, Annals of emergency medicine.

[22]  Alexander V Kabanov,et al.  Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. , 2002, Critical reviews in therapeutic drug carrier systems.

[23]  A. Kabanov,et al.  Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity. , 1996, British Journal of Cancer.

[24]  A. Kabanov,et al.  Fundamental Relationships Between the Composition of Pluronic Block Copolymers and Their Hypersensitization Effect in MDR Cancer Cells , 1999, Pharmaceutical Research.

[25]  W. Sawyer,et al.  Reversal of multidrug resistance by surfactants. , 1992, British journal of cancer.

[26]  R. Nalbandian,et al.  Pluronic F-127 gel preparation as an artificial skin in the treatment of third-degree burns in pigs. , 1987, Journal of biomedical materials research.

[27]  Donald W. Miller,et al.  Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells , 2000, Brain Research.

[28]  C. Vacanti,et al.  Tissue‐Engineered Nipple Reconstruction , 1998, Plastic and reconstructive surgery.

[29]  T. Johnston,et al.  Poloxamer 407-induced atherogenesis in the C57BL/6 mouse. , 1998, Atherosclerosis.

[30]  A. Allison,et al.  Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity. , 1987, Vaccine.

[31]  I. Tamai,et al.  Physiologically based pharmacokinetics of digoxin in mdr1a knockout mice. , 1999, Journal of pharmaceutical sciences.

[32]  B. Bennett,et al.  The Adjuvant Activity of Nonionic Block Polymer Surfactants , 1986, Scandinavian journal of immunology.

[33]  A. Kabanov,et al.  Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption. , 1997, Bioconjugate chemistry.

[34]  R. Gibbons,et al.  Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial. , 1996, Circulation.

[35]  K. Anderson,et al.  Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity. , 1995, Archives of biochemistry and biophysics.

[36]  R H Williams,et al.  Poloxamer 407-mediated changes in plasma cholesterol and triglycerides following intraperitoneal injection to rats. , 1992, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[37]  N. Rapoport,et al.  Effect of a polymeric surfactant on electron transport in HL-60 cells. , 2000, Archives of biochemistry and biophysics.

[38]  A. Kabanov,et al.  Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials , 1999 .

[39]  Paschalis Alexandridis,et al.  Amphiphilic Block Copolymers: Self-Assembly and Applications , 2000 .

[40]  R. Hunter,et al.  Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titre and isotype of antibody. , 1991, Vaccine.

[41]  Alexander V. Kabanov,et al.  Inhibition of Multidrug Resistance-Associated Protein (MRP) Functional Activity with Pluronic Block Copolymers , 1999, Pharmaceutical Research.

[42]  Alexander V. Kabanov,et al.  Pluronic P85 Increases Permeability of a Broad Spectrum of Drugs in Polarized BBMEC and Caco-2 Cell Monolayers , 1999, Pharmaceutical Research.

[43]  A. Allison,et al.  Adjuvant formulations and their mode of action. , 1990, Seminars in immunology.

[44]  I. R. Schmolka.  Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns. , 1972, Journal of biomedical materials research.

[45]  G. Badun,et al.  Interaction of tumor and normal blood cells with ethylene oxide and propylene oxide block copolymers , 1999, FEBS letters.

[46]  S. Mallapragada,et al.  Understanding drug release from poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) gels. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[47]  A. Allison,et al.  An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. , 1986, Journal of immunological methods.

[48]  S M Moghimi,et al.  Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. , 2000, Trends in biotechnology.

[49]  M. Keltai,et al.  The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarction. , 1997, Clinical hemorheology and microcirculation.

[50]  R. Hunter,et al.  Adjuvant activity of non-ionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A and precursors. , 1991, Vaccine.

[51]  R. Geyer.  Perfluorochemicals as oxygen transport vehicles. , 1987, Biomaterials, artificial cells, and artificial organs.

[52]  F. Follis,et al.  Role of poloxamer 188 during recovery from ischemic spinal cord injury: a preliminary study. , 1996, Journal of investigative surgery.

[53]  N. Melik-Nubarov,et al.  The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles , 1989, FEBS letters.

[54]  J. Coon,et al.  Comparison of solutol HS 15, cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents , 1995, International journal of cancer.

[55]  V. Alakhov,et al.  Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. , 1996, Cancer research.

[56]  D. Miller,et al.  Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. , 1998, Biochemical and biophysical research communications.

[57]  R. Bomford.  The adjuvant activity of fatty acid esters. The role of acyl chain length and degree of saturation. , 1981, Immunology.

[58]  V. Slepnev,et al.  Micelles of poly(oxyethylene)-poly(oxypropylene) block copolymer (pluronic) as a tool for low-molecular compound delivery into a cell: phosphorylation of intracellular proteins with micelle incorporated [gamma-32P]ATP. , 1992, Biochemistry international.

[59]  Donald W. Miller,et al.  Potential applications of polymers in the delivery of drugs to the central nervous system , 1999 .

[60]  Lisbeth Illum,et al.  Long circulating microparticulate drug carriers , 1995 .

[61]  R. Edlich,et al.  A new silver sulfadiazine water soluble gel. , 1997, Burns : journal of the International Society for Burn Injuries.

[62]  S. Davis,et al.  Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics , 1995 .

[63]  R. Borchardt,et al.  The Use of Surfactants to Enhance the Permeability of Peptides Through Caco-2 Cells by Inhibition of an Apically Polarized Efflux System , 1996, Pharmaceutical Research.

[64]  M. Kool,et al.  A family of drug transporters: the multidrug resistance-associated proteins. , 2000, Journal of the National Cancer Institute.

[65]  G Pifferi,et al.  Quality and functionality of excipients. , 1999, Farmaco.

[66]  Agren Ms.  An amorphous hydrogel enhances epithelialisation of wounds. , 1998 .

[67]  B. Williams,et al.  Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water-insoluble vitamins and drugs. , 1990, Cancer research.